Inventor
STEINMAN LAWRENCE
US34 patents
⚠️ This page may combine multiple inventors who share the name “STEINMAN LAWRENCE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV LELAND STANFORD JUNIOR
19 patentsUS4695459ASep 22, 1987
Method of treating autoimmune diseases that are mediated by Leu3/CD4 phenotype T cells
UNIV LELAND STANFORD JUNIOR65 citations93
US5939400AAug 17, 1999
DNA vaccination for induction of suppressive T cell response
UNIV LELAND STANFORD JUNIOR66 citations92
US5667967ASep 16, 1997
T-cell receptor varible transcripts as disease related markers
UNIV LELAND STANFORD JUNIOR85 citations92
US7030098B2Apr 18, 2006
DNA vaccination for treatment of autoimmune disease
UNIV LELAND STANFORD JUNIOR21 citations91
US5532265AJul 2, 1996
Treatment of central nervous system inflammatory disease with matrix metalloprotease inhibitors
UNIV LELAND STANFORD JUNIOR20 citations86
US7544669B2Jun 9, 2009
Polynucleotide therapy
UNIV LELAND STANFORD JUNIOR11 citations80
US6531130B1Mar 11, 2003
Treatment of demyelinating autoimmune disease with ordered peptides
UNIV LELAND STANFORD JUNIOR8 citations71
US5000952AMar 19, 1991
Polypeptide pertussis toxin vaccine
UNIV LELAND STANFORD JUNIOR7 citations69
US7704970B2Apr 27, 2010
DNA vaccination for treatment of autoimmune disease
UNIV LELAND STANFORD JUNIOR2 citations61
US7579328B2Aug 25, 2009
DNA vaccination for treatment of multiple sclerosis and insulin-dependent diabetes mellitus
UNIV LELAND STANFORD JUNIOR2 citations61
US7785819B2Aug 31, 2010
Therapeutic and diagnostic uses of antibody specificity profiles
UNIV LELAND STANFORD JUNIOR3 citations60
US7070780B2Jul 4, 2006
Treatment of demyelinating autoimmune disease with ordered peptides
UNIV LELAND STANFORD JUNIOR4 citations60
US7875589B2Jan 25, 2011
Alpha B-crystallin as a therapy for rheumatoid arthritis
UNIV LELAND STANFORD JUNIOR2 citations59
US7811813B2Oct 12, 2010
Methods and immune modulatory nucleic acid compositions for preventing and treating disease
UNIV LELAND STANFORD JUNIOR2 citations57
US10543260B2Jan 28, 2020
Replacement gene tolerizing vectors and methods of use thereof
UNIV LELAND STANFORD JUNIOR1 citations56
US7867976B2Jan 11, 2011
Nogo epitopic fragments for modulating immune response
UNIV LELAND STANFORD JUNIOR0 citations48
US10098935B2Oct 16, 2018
Aquaporin tolerizing vaccines and methods of use thereof
UNIV LELAND STANFORD JUNIOR0 citations45
US9610326B2Apr 4, 2017
Amyloid beta peptides as therapy for multiple sclerosis
UNIV LELAND STANFORD JUNIOR0 citations42
US7282490B2Oct 16, 2007
Osteopontin-related compositions and methods
UNIV LELAND STANFORD JUNIOR1 citations42
STEINMAN LAWRENCE
4 patentsUS10034915B2Jul 31, 2018
Small heat shock proteins and active fragments thereof as a therapy for inflammation and ischemia
STEINMAN LAWRENCE2 citations68
US8748404B2Jun 10, 2014
DNA vaccination for treatment of multiple sclerosis and insulin-dependent diabetes mellitus
STEINMAN LAWRENCE2 citations59
US8835391B2Sep 16, 2014
Alpha B-crystallin as a therapy for multiple sclerosis
STEINMAN LAWRENCE0 citations47
US8771689B2Jul 8, 2014
Alpha B-crystallin as a therapy for ischemia or inflammation
STEINMAN LAWRENCE0 citations47
NEUROCRINE BIOSCIENCES INC
2 patentsUS6329499B1Dec 11, 2001
Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein
NEUROCRINE BIOSCIENCES INC10 citations72
US6740638B2May 25, 2004
Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein
NEUROCRINE BIOSCIENCES INC3 citations61
STANFORD UNIVERSITY MEDICAL CT
2 patentsUS6489299B2Dec 3, 2002
Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein
STANFORD UNIVERSITY MEDICAL CT12 citations71
US6369033B1Apr 9, 2002
Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein
STANFORD UNIVERSITY MEDICAL CT3 citations60